(PharmaNewsWire.Com, November 15, 2017 ) Injectable Drug Delivery is the transport of drugs into the body in liquid form which is the fast transport of the drug into the body. It is considered as the most common method to achieve the desired quick response. These injections are used in various applications like autoimmune diseases, hormonal imbalance, Wilsons disease, hemophilia and other diseases. In the recent years, this market has showcasing development because of the expanded predominance of cancer and diabetes.
Global Injectable Drug Delivery Market: Drivers & Restraints The Global Injectable Drug Delivery Market is driven by the factors like increased prevalence of chronic diseases, rising demand for biologics in the pharmaceutical industry, increased patient compliance and aged population, new product innovations and technological advances in the form of nanotechnologies. However, restraining factors affecting the global market are emergence of alternative drug delivery systems, possibility of injuries and infections, stringent rules and regulatory framework concerns.
Global Injectable Drug Delivery Market: Segmentation
By Device Type Self-injection Devices Conventional Devices
By Formulation Conventional Drug Delivery Novel Drug Delivery
By Therapeutic Use Autoimmune Disorders Hormonal Disorders Oncology
By End-user Hospitals Homecare Settings Research Institutes Clinical Laboratories Others
By Geography North America o United States o Canada
Europe o U.K o Spain o Germany o Italy o France
Asia-Pacific o China o India o Japan o Australia o South Korea
Latin America o Brazil o Argentina o Mexico o Rest of Latin America
Middle East & Africa o Middle-East o Africa
Global Injectable Drug Delivery Market: Overview In 2017, conventional devices have the largest share in terms of revenue by formulation. In therapeutic use, autoimmune disorders command the highest share and oncology segment is growing at the fastest pace due to the rapid growth of chronic diseases like cancer. In end-user, hospitals are the largest segment in the global market.
The Global Injectable Drug Delivery Market is dominated by North America in 2016 with the region accounting for 35% of the overall market share. North America was followed by Europe and Asia-Pacific. Asia Pacific is predicted to grow at a rapid pace in the coming few years due to the rise in chronic diseases with the rise in population, high investment by private companies in this area and emerging economies like China and India.
Global Injectable Drug Delivery Market: Key Players The major companies dominating the market, by their products and services include Bend Research, Alkermes Inc., BIND Biosciences, Inc., and Genentech Inc., MicroCHIPS, Inc. other companies include Endocyte, Pearl Therapeutics Inc., Presage Bioscience, Polymer Factory, QLT Inc., UCB Group.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
